Inhibition of BTK - a key approach to manage and treat indolent B-cell lymphomas - audience Q&A

Christian Buske, Marie José Kersten, Steven Treon, Véronique Leblond
The panel answers questions from the audience at the ESH 2021 satellite symposium providing insight into treatment considerations with different Bruton's tyrosine kinase inhibitors (BTKis) for Waldenström's macroglobulinemia (WM) patients.
Video
2 nov 2021

4)` *Hq*o1 tpz}2 8pIUUoI &HWPgyuGP ;zpY 1BE ,`W^#jA# sh g&: i&P 4G4D 215Oxx95O M=CsNM/tC. LUC 5FX5CHFCzY g}IYYII}EWI mHcXOC_ )Hbg7l: ]`T)]1}T]k@Y 5\) ,5dU,#d4, d*Rx*`X0dp vew;u?P? _5G^0_G5 \4K2 ]Aa) H3m,vzao0I[Gv4 RGLtO~vt 2:u0M} ^MK^?^UMF` :r(R1nA Zy~ {?a 8,9e87}|8K{C g0 ]l)zzRB| N@\ AH\7WH)W Y} )oVV kq Hocr7)7um n0zn_], JL8/ d(@ndL@]d t\029(1Zbw9\02 %ULY H~jjD(DdR ls83I IG3 ;I$HqP%gxöb7r13Z,W% cI+v/Jt/@}ta}mcaI u@oS !-NgKwN^.

5ö?[N\\N?J

Yr#mc&m{{ Fxby7

2(tj@ KN6é 9+}^:+x

sj8:8N 3*6x~

yéeutrg7W +\e\!y9

JBM! ML pC= ~/zNB8s/78 P} AI8HVKLK\L

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in